De-Escalation Has Lasting Benefits for HER2+ Breast Cancers

If diagnosed at an early stage, HER2-positive tumors have a good prognosis and can be treated with less aggressive and less toxic chemotherapies.
Medscape Medical News

source https://www.medscape.com/viewarticle/990456?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?